Health care costs

FILE - This Tuesday, June 16, 2020 file photo shows a bottle and box for dexamethasone in a pharmacy in Omaha, Neb. New studies confirm that cheap steroid drugs improved survival for severely ill COVID-19 patients, cementing this as a standard of care and expanding options to more types than this one previously shown to help. (AP Photo/Nati Harnik)
September 02, 2020 - 11:32 am
New studies confirm that multiple types of steroids improve survival for severely ill COVID-19 patients, cementing the cheap drugs as a standard of care. An analysis of pooled results from seven studies, led by the World Health Organization and published Wednesday by the Journal of the American...
Read More
President Donald Trump speaks during an event to sign executive orders on lowering drug prices, in the South Court Auditorium in the White House complex, Friday, July 24, 2020, in Washington. (AP Photo/Alex Brandon)
July 24, 2020 - 9:23 pm
WASHINGTON (AP) — Unable to land the big deal with Congress to curb drug costs, President Donald Trump on Friday moved on his own to allow imports of cheaper medicines, along with other limited steps that could have some election-year appeal. At a White House ceremony, Trump signed four executive...
Read More
House Speaker Nancy Pelosi of Calif., speaks at a news conference on Capitol Hill in Washington, Friday, June 26, 2020. (AP Photo/Carolyn Kaster)
June 29, 2020 - 12:08 pm
WASHINGTON (AP) — Democrats pushed a strengthening of “Obamacare” patient protections toward House passage Monday, an effort they hoped would help them sharpen the coronavirus pandemic and President Donald Trump's efforts to scuttle the increasingly popular law into a lethal campaign-season weapon...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
June 29, 2020 - 11:54 am
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for...
Read More
FILE - In this March 22, 2020, file photo Vice President Mike Pence speaks alongside President Donald Trump during a coronavirus task force briefing at the White House in Washington. Pence says the U.S. response to the coronavirus pandemic is “a cause for celebration,” but a new poll finds more than half of Americans calling it fair or poor. (AP Photo/Patrick Semansky, File)
June 18, 2020 - 1:31 am
WASHINGTON (AP) — Vice President Mike Pence says the U.S. response to the coronavirus pandemic is “a cause for celebration,” but a new poll finds more than half of Americans calling it fair or poor. The Gallup and West Health survey out Thursday found that 57% of U.S. adults rated the national...
Read More
FILE - In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. In a major legal setback for President Donald Trump on a high-profile consumer issue, a federal appeals court has ruled that his administration lacks the legal authority to force drug companies to disclose prices in their TV ads. (AP Photo/Elise Amendola, File)
June 17, 2020 - 1:01 pm
WASHINGTON (AP) — In a major legal setback for President Donald Trump on a high-profile consumer issue, a federal appeals court has ruled that his administration lacks the legal authority to force drug companies to disclose prices in their TV ads. The ruling denies Trump an easy-to-understand win...
Read More
This microscope image made available by the National Cancer Institute Center for Cancer Research in 2015 shows human colon cancer cells with the nuclei stained red. On Friday, May 29, 2020, doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. (NCI Center for Cancer Research via AP)
May 29, 2020 - 8:01 am
Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. Gentler drugs would be a relief to patients like Jenn Carroll, a 57-year-old human resources director from New Hartford,...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas.At least 13 states have obtained a total of more than 10 million doses of malaria drugs to treat COVID-19 patients despite warnings from doctors that more tests are needed before the medications that President Trump once fiercely promoted should be used to help people with the coronavirus. (AP Photo/John Locher,File)
April 28, 2020 - 7:31 pm
OKLAHOMA CITY (AP) — Republican state leaders in Oklahoma and Utah are facing scrutiny for spending millions of dollars combined to purchase malaria drugs promoted by President Trump to treat COVID-19 patients that many other states obtained for free and that doctors warned shouldn't be used...
Read More
In this April 23, 2020, photo, contract workers join the Army Corps of Engineers as they get the currently dormant St. Luke's Hospital ready for reopening for the possible surge of coronavirus patients in Phoenix. As states gear up to reopen, a poll finds a potential obstacle to controlling coronavirus: nearly 1 in 10 adults say cost would keep them from seeking help if they thought they were infected. The Gallup-West Health Healthcare Costs Survey out Tuesday, April 28, finds that 9% of those age 18 and over would avoid seeking treatment because of concerns about the cost of care, even if they thought they were infected with the coronavirus. (AP Photo/Ross D. Franklin)
April 28, 2020 - 1:31 am
WASHINGTON (AP) — As states gear up to reopen, a poll finds a potential obstacle to controlling coronavirus: nearly 1 in 10 adults say cost would keep them from seeking help if they thought they were infected. The Gallup-West Health Healthcare Costs Survey out Tuesday finds that 9% of those age 18...
Read More
In this image provided by U.S. Centers for Medicare & Medicaid Service, the website for HealthCare.gov is seen. The Trump administration’s opposition to “Obamacare” could become an obstacle to helping millions of uninsured people in the coronavirus outbreak, as well as many workers who are losing coverage because of the economic shutdown. Experts say the Affordable Care Act’s insurance markets provide an infrastructure for extending subsidized private coverage in every state. (U.S. Centers for Medicare & Medicaid Service via AP)
April 13, 2020 - 6:40 pm
WASHINGTON (AP) — The Trump administration’s unrelenting opposition to “Obamacare” could become an obstacle for millions of uninsured people in the coronavirus outbreak, as well as many who are losing coverage in the economic shutdown. Experts say the Affordable Care Act's insurance markets provide...
Read More

Pages